Robert Azelby - 10 Jun 2021 Form 4 Insider Report for Clovis Oncology, Inc.

Role
Director
Signature
/s/ Robert Azelby
Issuer symbol
N/A
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 21:07:52 UTC
Next filing
09 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLVS Stock Option (right to buy) Award $0 +42,223 $0.000000 42,223 10 Jun 2021 Common Stock 42,223 $5.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest on the one-year anniversary of the date of grant.